Exponent Q1 2026: Crushing Estimates, Strong Momentum

Exponents Q1 2026 results show a 21% revenue increase to $166.3M, surpassing estimates and boosting EPS to $0.59. Adjusted EBITDA reached $52.19M, with operating margins at 24.9%. Despite a dip from last year, the companys multidisciplinary strengths drive demand. Stock remained stable at $67. Analysts predict modest revenue growth, but this quarters strong performance indicates potential for steady growth in their niche expertise. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/9a738e2b595d3955